Recent News and Updates
Introducing RareValue - A decision model for preclinical and clinical stage investments to help unleash the full treatment and commercialization potential in rare and orphan diseases. RareValue is a robust and repeatable analytic tool for the 7,000 rare and orphan diseases that represent different risk/reward dynamics. This interactive tool assesses the potential of molecules while enabling filtering by therapy type (e.g. gene therapy, cell therapy) and considering regional differences. Click here for more information.
Wondering how Covid-19 will affect orphan drug development? Check out our latest blog post, Covid-19 and the Rare Disease Sector to learn about the pandemic's impact on the orphan space.